Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study

AIMS: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) (NCT02072434) study was a multicentre prospective, randomized, open-label, blinded-endpoint evaluation (PROBE) trial comparing edoxaban with enoxaparin/warfarin followed by warfarin alone in 2199...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Europace
Main Authors: Goette, Andreas, Kwong, Winghan J, Ezekowitz, Michael D, Banach, Maciej, Hjortshoj, Soren P, Zamoryakhin, Dmitry, Lip, Gregory Y H
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Clinical Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6275467/
https://ncbi.nlm.nih.gov/pubmed/29947751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/europace/euy141
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki